Source: Abstract. Conference titles: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, CÉLULAS-TRONCO (TRANSPLANTE)
ABNT
OLIVEIRA, Gislane Lelis Vilela et al. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 12 set. 2024.APA
Oliveira, G. L. V., Malmegrim, K., Ferreira, A., Gasparotto, E., Kashima, S., Covas, D. T., et al. (2007). Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. In Abstract. São Paulo: ABCF.NLM
Oliveira GLV, Malmegrim K, Ferreira A, Gasparotto E, Kashima S, Covas DT, Voltarelli JC, Castro FA de. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. Abstract. 2007 ;[citado 2024 set. 12 ]Vancouver
Oliveira GLV, Malmegrim K, Ferreira A, Gasparotto E, Kashima S, Covas DT, Voltarelli JC, Castro FA de. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. Abstract. 2007 ;[citado 2024 set. 12 ]